Meanwhile, the drug development unit, provisionally dubbed SpinCo, will retain ties with Gilead, which will remain a collaboration partner and have representation on its board. The decision comes ...

VANCOUVER, BC / ACCESS Newswire / June 18, 2025 / (TSXV:OGN)(OTCQX:OGNRF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce that Institutional Shareholder Services Inc ...